4//SEC Filing
THOMSON TODD S 4
Accession 0001011438-26-000005
CIK 0001652935other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 12:45 PM ET
Size
10.3 KB
Accession
0001011438-26-000005
Insider Transaction Report
Form 4
THOMSON TODD S
Director10% Owner
Transactions
- Sale
Common Stock
2026-01-05$5.80/sh−280,000$1,624,000→ 904,795 total(indirect: By Kairos Venture Partners II, L.P.)
Holdings
- 873,033(indirect: By Kairos Venture Opportunities I, L.P.)
Common Stock
- 321,781(indirect: By LLC)
Common Stock
- 254,735(indirect: By Kairos-Actuate SPV, L.P.)
Common Stock
Kairos Venture Partners II, L.P.
Director10% Owner
Transactions
- Sale
Common Stock
2026-01-05$5.80/sh−280,000$1,624,000→ 904,795 total(indirect: By Kairos Venture Partners II, L.P.)
Holdings
- 873,033(indirect: By Kairos Venture Opportunities I, L.P.)
Common Stock
- 321,781(indirect: By LLC)
Common Stock
- 254,735(indirect: By Kairos-Actuate SPV, L.P.)
Common Stock
Footnotes (2)
- [F1]The securities of Actuate Therapeutics, Inc. ("Actuate") that are reported herein are held directly by Kairos-Actuate SPV, L.P., Kairos Venture Partners II, L.P., Kairos Venture Opportunities I, L.P., and Kairos SPV Fund, LLC (collectively, the "Kairos Funds"). The Kairos Funds are managed and controlled by Kairos Venture Investments, LLC ("KVI"), subject to the Limited Partnership Agreements in place for each Kairos Fund. Todd Thomson serves as Chief Financial Officer/Chief Operating Officer of KVI and is a director on the board of directors of Actuate. James Demetriades is the Chief Executive Officer of KVI.
- [F2]Each of KVI, Mr. Thomson and Mr. Demetriades may be deemed to indirectly beneficially own the securities of Actuate held directly by the Kairos Funds. Each of KVI, Mr. Thomson and Mr. Demetriades disclaims beneficial ownership of the securities of Actuate held directly by the Kairos Funds except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that any of KVI, Mr. Thomson or Mr. Demetriades is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
Documents
Issuer
ACTUATE THERAPEUTICS, INC.
CIK 0001652935
Entity typeother
Related Parties
1- filerCIK 0001225707
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 12:45 PM ET
- Size
- 10.3 KB